Skip to main content

RM56 RM56 (Sunitinib Malate 50 mg)

Pill with imprint RM56 RM56 is Tan, Capsule-shape and has been identified as Sunitinib Malate 50 mg. It is supplied by Sun Pharmaceutical Industries Inc.

Sunitinib is used in the treatment of gastrointestinal stromal tumor; renal cell carcinoma; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RM56 RM56

Sunitinib Malate

Imprint
RM56 RM56
Strength
50 mg
Color
Tan
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sun Pharmaceutical Industries Inc.
National Drug Code (NDC)
63304-0094
Inactive Ingredients
croscarmellose sodium, magnesium stearate, mannitol, povidone k30, ferric oxide red, ferric oxide yellow, ferrosoferric oxide, titanium dioxide, potassium hydroxide, shellac, gelatin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "RM56 RM56"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.